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Abstract
Adrenal zona fasciculata (AZF) cells express a cAMP-activated guanine nucleotide exchange protein (Epac2) that may
function in ACTH-stimulated cortisol synthesis. Experiments were done to determine whether cAMP analogs that selectively
activate Epacs could induce cortisol synthesis and the expression of genes coding for steroidogenic proteins in bovine AZF
cells. Treatment of AZF cells with the Epac-selective cAMP analog (ESCA) 8CPT-29-OMe-cAMP induced large (.100 fold),
concentration-dependent, delayed increases in cortisol synthesis and the expression of mRNAs coding for the steroid
hydroxylases CYP11a1, CYP17, CYP21, and the steroid acute regulatory protein (StAR). However, a non-hydrolyzable analog
of this ESCA, Sp-8CPT-29-OMe-cAMP, failed to stimulate cortisol production even at concentrations that activated Rap1, a
downstream effector of Epac2. Accordingly, putative metabolites of 8CPT-29-OMe-cAMP, including 8CPT-29-OMe-59AMP,
8CPT-29-OMe-adenosine, and 8CPT-adenine all induced cortisol synthesis and steroid hydroxylase mRNA expression with a
temporal pattern, potency, and effectiveness similar to the parent compound. At concentrations that markedly stimulated
cortisol production, none of these metabolites significantly activated cAMP-dependent protein kinase (PKA). These results
show that one or more metabolites of the ESCA 8CPT-29-OMe-cAMP induce cortico-steroidogenesis by activating a panel of
genes that code for steroidogenic proteins. The remarkable increases in cortisol synthesis observed in this study appear to
be mediated by a novel cAMP-, Epac- and PKA-independent signaling pathway.
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Introduction
Cortisol is synthesized from cholesterol and secreted by adrenal
zona fasciculata (AZF) cells in a diurnal rhythm under the control
of the pituitary peptide adrenocorticotropic hormone (ACTH) [1].
Superimposed on this oscillatory pattern of secretion, stress-
induced activation of the hypothalamic-pituitary-adrenal axis leads
to additional ACTH-stimulated cortisol production [2]. In AZF
cells, the effects of ACTH are mediated through an MC2R
melanocortin receptor whose activation is coupled to cAMP
synthesis through Gs [3–5].
ACTH stimulates corticosteroid synthesis through two tem-
porally distinct cAMP-dependent processes. The acute phase
occurs within minutes, is independent of gene transcription, and
is initiated by the mobilization and delivery of cholesterol to
intracellular sites where steroidogenic enzymes are located
[1,6,7]. The delayed increase in cortisol synthesis is mediated
through the enhanced transcription of genes coding for
steroidogenic proteins, including the steroidogenic acute regula-
tory protein (StAR) which transfers cholesterol from the outer to
the inner mitochondrial membrane, and the steroidogenic
enzymes that mediate the stepwise conversion of cholesterol to
cortisol [1,6,8–10]. Most of these enzymes belong to the
cytochrome P450 family of mixed function oxidases [11]. cAMP
increases mRNA coding for these proteins within hours, with a
temporal pattern resembling that produced by ACTH
[1,6,8,9,12,13].
Until recently, nearly all of the actions of cAMP in eukaryotic
cells were believed to be mediated through the activation of
cAMP-dependent protein kinase (PKA). However, two cAMP-
activated guanine nucleotide exchange factors (Epac1 and Epac2,
also known as cAMP-GEFI and cAMP-GEFII) that activate the
small GTPases Rap1 and Rap2 have been identified [14,15].
Epac1 and Epac2 function in various cellular processes, including
the secretion of peptide hormones and neurotransmitters [16–18].
While Epac1 is widely expressed mammals, the expression of
Epac2 is restricted to a few tissues including the adrenal gland
[14,15].
In this regard, the adrenal gland consists of an inner medulla
composed of neural crest-derived chromaffin cells and an outer
cortex that includes corticosteroid-secreting cells of mesodermal
origin [2]. The adrenal cortex includes aldosterone-secreting zona
glomerulosa cells and cortisol-secreting cells of the zona fasciculata
(AZF). Although Epac2 is highly expressed in AZF cells [19], it
isn’t known if cAMP-dependent activation of Epac2 might
contribute to ACTH-stimulated cortisol production.
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delayed stimulation of cortisol synthesis, have long been attributed
to the activation of PKA; however, confounding evidence exists.
Specifically, genes that code for steroidogenic enzymes in AZF
cells are induced by cAMP, yet nearly all of these, regardless of
species, lack consensus cAMP response elements in the 59 flanking
region and therefore do not bind PKA phosphorylated transcrip-
tion factors [8,20–24].
Further, PKA-stimulated transcription typically occurs with
rapid kinetics and does not require de novo protein synthesis [25]. In
contrast, ACTH- or cAMP-induced increases in steroid hydrox-
ylase-specific mRNAs are cycloheximide sensitive and require
periods of up to several hours before they are observed [8,20,25].
Therefore, ACTH and cAMP may increase the transcription of
steroidogenic enzymes, and stimulate cortisol synthesis by novel
PKA-independent mechanisms.
In this regard, PKA-independent actions of ACTH and cAMP
have been reported in AZF cells. cAMP inhibits bTREK-1 K
+
channels in AZF cells by a mechanism that is independent of PKA,
but mimicked by Epac-specific cAMP analogs [19,26]. ACTH
enhances the expression of T-type Ca
2+ channels in rat AZF cells
by an H-89 insensitive mechanism [27].
Elucidating the signaling pathways by which ACTH and cAMP
regulate corticosteroid synthesis has been hampered by the lack of
specific reagents that could independently modulate PKA and
Epacs. Exploiting differences in the cAMP-binding domains of
these proteins, rational drug design has recently been used to
synthesize cAMP derivatives that, at appropriate concentrations,
selectively activate Epacs or PKA. These derivatives provide the
opportunity to independently study cAMP-activated proteins in
the regulation of cell function [28–30].
One of these, 8CPT-29-OMe-cAMP, selectively activates Epacs
over PKA, and has been used extensively to determine the role of
Epac1 and Epac2 in cell function [28,30]. However, in the present
study we found that, in AZF cells, 8CPT-29-OMe-cAMP
stimulated large, delayed increases in the expression of steroid
hydroxylase mRNAs and cortisol synthesis by an Epac-indepen-
dent mechanism. These effects were mediated by one or more
metabolites of the parent compound through an unknown
signaling pathway.
Methods
Materials
DMEM/F12, antibiotics, fibronectin, and fetal bovine sera
(FBS) were obtained from Invitrogen (Carlsbad, CA). Ultrahyb
was purchased from Ambion (Austin, TX) and Prime-It II kit for
random priming was purchased from Stratagene (La Jolla, CA).
Phosphate buffered saline (PBS), tocopherol, selenite, ascorbic
acid, and ACTH (1–24) were obtained from Sigma (St. Louis.
MO). 8-(4-chlorophenylthio)-29-O-methyl-cAMP (8CPT-29-OMe-
cAMP -Biolog #C041), hydrolysis-resistant 8-(4-chlorophe-
nylthio)-29-O-methyl-cAMPs, Sp-isomer (Sp-8CPT-29-OMe-
cAMP - Biolog # C052), 8-(4-chlorophenylthio)-29-O-methylade-
nosine-59-O-monophosphate (8CPT-2-OMe-59AMP – Biolog #
C078), 8-(4-chlorophenylthio)-29-O-methyladenosine (8CPT-
29OMe-Ado – Biolog #C070), and 8-(4-chlorophenylthio) ade-
nine (8CPT-Ade – Biolog #C069) were purchased from
Axxora,LLC (San Diego, CA). Cortisol EIA kit was from
Diagnostic Systems Laboratories (Webster, TX). Rap1 activation
assay kit was purchased from Millipore (Billerica, MA) and
SignaTECT cAMP-dependent protein kinase assay kit was from
Promega (Madison, WI).
Isolation and Culture of AZF Cells
Bovine adrenal glands were obtained from steers (age 2–3 yr) at
a local slaughterhouse. AZF cells were isolated as previously
described [31]. After isolation, cells were either resuspended in
DMEM/F12 (1:1) with 10% FBS, 100 U/ml penicillin, 0.1 mg/
ml streptomycin, and the antioxidants 1 mM tocopherol, 20 nM
selenite and 100 mM ascorbic acid (DMEM/F12+) and plated for
immediate use, or resuspended in FBS/5% DMSO, divided into
aliquots, and stored in liquid nitrogen for future use. To ensure
attachment when plating cells, dishes were treated with fibronectin
(10 mg/ml) for 30 minutes then rinsed with warm, sterile PBS
before adding cells. Cells were maintained at 37uC in a humidified
atmosphere of 95% air-5% CO2. For experiments where cortisol
alone was measured, cells were plated at a density of 0.5–1.0610
6
cells/35 mm dish. For experiments where cortisol was measured
and RNA was isolated from cell lysates, cells were plated at a
density of 5–7610
6 cells/60 mm culture dish. For all experiments
except those for Rap1, cells were plated 24 h before incubating
with ESCAs or metabolites. For Rap1 assay, cells were plated 48 h
before incubating with 8CPT-29-OMe-cAMP or Sp-8CPT-29-
OMe-cAMP.
Cortisol Assay
Media from experiments was either assayed immediately after
collection or frozen (220uC) until all samples were available. Each
experimental condition was assayed in duplicate and duplicate
media samples from each were measured using a Cortisol EIA
(DSL-10-200) from Diagnostic Systems Laboratories (Webster,
TX), according to the manufacturer’s directions. If necessary,
media samples were diluted using DMEM/F12+. Cortisol values
are expressed as mean6SEM of duplicate independent determi-
nations, assayed in duplicate.
Northern Blot and Measurement of mRNA
Total RNA isolation and Northern blot procedures have been
described previously [32]. Briefly, 5–7610
6 AZF cells were plated
on 60-mm fibronectin-treated dishes in DMEM/F12+. After 24 h,
the serum-supplemented media were removed and replaced with
either control media (DMEM/F12+) or the same media
containing ACTH (1–24), 8CPT-29-OMe-cAMP, Sp-8CPT-29-
OMe-cAMP, or other agents as required. At the end of the
incubation period, total RNA was extracted using RNeasy
columns (Qiagen, Valencia, CA), electrophoresed on a denaturing
gel, and transferred to a nylon transfer membrane (GeneScreen
Plus, PerkinElmer Life Sciences, Waltham, MA). Probes were
generated by RT-PCR using AMV reverse transcriptase (Pro-
mega, Madison WI), specific primers, and total RNA isolated from
bovine AZF cells as described above. Specific probes generated
were as follows: StAR- bases 104-1047 of NM_174189, CYP11a1-
bases 679-1816 of NM_176644, CYP17 - bases 68-755 of
NM_174303, CYP21 – bases 491-1240 of NM_001013596.
Probes were labeled with [a-
32P]dCTP by random primer labeling
(Prime-It II, Stratagene, La Jolla, CA). Northern autoradiograms
were imaged using a Typhoon 9200 variable mode imager and
quantitated using ImageQuant TL v2003.3 software (GE
Healthcare Life Sciences, Piscataway, NJ). mRNA values are
presented as mean6SEM of at least 3 independent determina-
tions. For the figures, a representative Northern blot is shown for
each set of experiments.
Rap1 Activation Assay
Rap1 activation assays using a glutathione reductase-tagged
fusion protein corresponding to amino acids 788–884 of the
Cortisol Secretion Pathway
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agarose (Ral GDS-RBD agarose) were performed using a Rap1
activation assay kit according to the manufacturer’s directions
(Millipore, Billerica, MA). Briefly, ,10610
6 cells were plated on
fibronectin-treated 10 cm plates in DMEM/F12+ for 48 h,
changed to serum-free DMEM for 12 hours, directly stimulated
with Epac activators for 15 min, washed twice with ice-cold TBS,
then lysed in 600 ml of buffer containing 0.05 M Tris/HCl
(pH 7.4), 0.5 M NaCl, 1% NP-40, 2.5 mM MgCl2, 5% glycerol,
and protease inhibitors (Complete, EDTA-free, Roche Applied
Science, Mannheim, Germany). Cells were disrupted by passing
lysate five times through a 29-gauge needle; lysate was cleared by
centrifugation at 14 000 g for 10 min at 4uC. An aliquot (60 ml) of
the supernatant was reserved for estimation of total Rap1.
Remaining supernatant was mixed with glutathione-agarose and
incubated for 1 h at 4uC. Samples were then centrifuged at 10
000 g for 30 s at 4uC, washed 36with lysis buffer, suspended in
40 mlo f2 6 Laemmle buffer containing 10 mM DTT, and
separated by 8–16% SDS-PAGE gel electrophoresis. Proteins
were transferred to polyvinylidene fluoride (PVDF) membrane,
incubated with polyclonal anti-Rap1 antibodies (Millipore, Bill-
erica, MA), and visualized by enhanced chemilluminescence
(Pierce of Thermo Fisher Scientific, Rockford, IL).
A-kinase Assay
PKA activity was measured with a SignaTECT cAMP-
dependent protein kinase assay kit (Promega, Madison, WI) in
which PKA-dependent phosphorylation of biotinylated peptides
can be quantitatively measured as a function of PKA activity. AZF
cells were plated on 60-mm fibronectin-treated dishes in DMEM/
F12+ at a density of 4610
6 cells/dish. After 24 h, the media was
replaced with either control media (DMEM/F12+) or the same
media containing ACTH (1–24), 8CPT-29-OMe-cAMP, Sp-
8CPT-29-OMe-cAMP, or other agents as required. At the end
of the incubation period, cells were washed 46with ice-cold PBS,
suspended in cold extraction buffer (25 mM Tris-HCl pH 7.4,
0.5 mM EGTA, 10 mM b-mercaptoethanol, 0.5 mM Pefabloc-
SC (Roche Applied Science, Indianapolis, IN), and protease
inhibitors with EDTA (Complete Mini protease inhibitor cocktail
tablet (Roche Applied Science, Indianapolis, IN), 1 per 10 mls lysis
solution). Lysates were homogenized using a cold Dounce
homogenizer, then centrifuged for 5 min at 4uC, 14,0006 g.
Each experimental condition was assayed in duplicate, and
duplicate 5 ml samples of lysate supernatant from each were tested
for PKA activity according to the manufacturer’s directions.
Maximum activatable PKA activity was obtained for each
respective sample by the addition of cAMP (5 mM) directly to
the sample lysates before determining PKA activity according to
the manufacturer’s directions. PKA values are presented as
mean6SEM.
Results
8CPT-29-OMe-cAMP induces a delayed increase in
Cortisol Secretion by AZF Cells
When applied to bovine AZF cells, the ESCA 8CPT-29-OMe-
cAMP produced a remarkable concentration-dependent, delayed
increase in cortisol secretion. As illustrated in Figure 1A, a 4 h
exposure to 8CPT-29-OMe-cAMP at concentrations between 10
and 50 mM produced little or no increase in the quantity of cortisol
secreted. However, by 24 h, large 4 to 15 fold increases in the
quantity of cortisol produced were present. Between 24 and 48 h,
the ESCA induced even greater increases in the rate of secretion;
by 48 h, 8CPT-29-OMe-cAMP (50 mM) had increased the
quantity of cortisol produced more than 20 times the control
value. 8CPT-29-OMe-cAMP stimulated cortisol synthesis with an
EC50 of 23 mM (Figure 1B).
ACTH stimulates cortisol secretion through rapid and delayed
cAMP-dependent mechanisms that are incompletely understood
[1,13]. Experiments with 8CPT-29-OMe-cAMP suggested that the
delayed effects of ACTH on cortisol synthesis could be mediated
through activation of Epac2. ACTH was compared to 8CPT-29-
OMe-cAMP with respect to the time-dependent stimulation of
cortisol production for periods from 1 to 96 h. While ACTH-
induced increases in the rate of cortisol secretion were present by
1 h and subsided by 48 h, the delayed 8CPT-29-OMe-cAMP-
stimulated increases in the rate of cortisol synthesis persisted for at
least 96 h (Figure 1C,D).
8CPT-29-OMe-cAMP Stimulates Expression of Steroid
Hydroxylase mRNAs
The delay of many hours that preceded 8CPT-29-OMe-cAMP-
stimulated cortisol secretion suggested that the response was
mediated through an action on gene transcription. CYP11a1,
CYP17, and CYP21 are three of the steroid hydroxylases that
mediate the stepwise synthesis of cortisol from cholesterol.
CYP11a1 is a mitochondrial enzyme that catalyses the synthesis
of pregnenolone from cholesterol, the first and rate-limiting
enzymatic step in cortisol synthesis. CYP17 and CYP21 are
microsomal enzymes [6]. 8CPT-29-OMe-cAMP (10-50 mM)
induced concentration-dependent increases in the expression of
each of the three steroid hydroxylase mRNAs. In the experiment
illustrated in Figure 2A, maximum increases ranged from over
three fold (3.361.1, n=7) for CYP11a1 to 20 fold (20.662.6,
n=6) for CYP17. The increases in CYP17 mRNA were typically
greatest relative to time-matched controls since this is the only one
of the steroid hydroxylases whose expression is reported to be
entirely cAMP-dependent [33,34]. The 8CPT-29-OMe-cAMP-
stimulated increases in the quantity of mRNAs for each of the
steroid hydroxylases occurred only after a delay of more than 4 h,
while mRNA levels continued to increase for periods up to 72 h
(Figure 2B,C).
The induction of the steroid hydroxylase mRNAs by the ESCA
was not reduced by the PKA antagonist H-89. Overall, H-89
(10 mM) did not significantly affect 8CPT-29-OMe-cAMP-induced
CYP17 and CYP11a1 expression (Figure 2B).
The kinetics of ACTH and 8CPT-29-OMe-cAMP stimulation
of steroid hydroxylase mRNA expression were consistent with
their actions on cortisol secretion. In the experiments illustrated in
Figure 2C, the kinetics of ACTH and 8CPT-29-OMe-cAMP
induction of CYP17 mRNAs were compared at times from 0.5 to
30 h. ACTH induced large increases in CYP17 mRNA that were
present after 4 h, and reached a maximum of 20 fold by 20 h. In
contrast, 8CPT-29-OMe-cAMP stimulated a slower, delayed
increase in CYP17 mRNA that was significant at 10 h, but had
not reached a maximum by 30 h. Similar results were obtained for
CYP11a, and CYP21 (data not shown).
Sp-8CPT-29-OMe-cAMP does not Stimulate Cortisol
Synthesis
The ability of 8CPT-29-OMe-cAMP to induce large increases in
the expression of steroid hydroxylase mRNAs and cortisol
synthesis by bovine AZF cells suggested that the delayed actions
of ACTH and cAMP on cortico-steroidogenesis are mediated
through activation of Epac2. However, similar to cAMP, this
ESCA is metabolized by cyclic nucleotide phosphodiesterase as
well as other enzymes [30]. To determine whether the
Cortisol Secretion Pathway
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this compound rather than a metabolite, we measured the effect of
the poorly hydrolyzable analog Sp-8CPT-29-OMe-cAMP on
cortisol synthesis and the expression of steroid hydroxylase
mRNAs. Although Sp-8CPT-29-OMe-cAMP activates Epac
proteins with a potency similar to its hydrolyzable analog
[30,35], the non-hydrolyzable compound at concentrations up to
100 mM was ineffective at increasing cortisol secretion or
enhancing the expression of steroid hydroxylase mRNAs
(Figure 3A,C,D). By comparison, at 100 mM, 8CPT-29-OMe-
cAMP and its non-hydrolyzable analog activated Rap1 similarly
(Figure 3B).
These results indicated that the substantial increases in steroid
hydroxylase mRNAs and cortisol secretion induced by 8CPT-29-
OMe-cAMP were not mediated through Epac2. They further
suggested that this response required the conversion of this ESCA
to one or more active metabolites.
Effect of Metabolites of 8CPT-29-OMe-cAMP on
Steroidogenesis
8CPT-29-OMe-cAMP can be converted to 8CPT-29-OMe-
59AMP by cyclic nucleotide phosphodiesterase (see Figure 4)
[30,36]. This metabolite stimulated cortisol secretion and
expression of steroid hydroxylase with a temporal pattern,
potency, and effectiveness similar to the parent ESCA (Figure 5).
In the experiment illustrated, a 6 h exposure to 8CPT-29-OMe-
59AMP (100 mM) did not significantly increase cortisol synthesis.
However, by 48 h, cortisol production increased 400 fold.
Accordingly, after 48 h, 8CPT-29-OMe-59AMP (50 mM) had
induced a nearly 50 fold (49.661.9, n=3) increase in CYP17.
Figure 1. Time- and Concentration-dependent Effects of ACTH and 8CPT-29-OMe-cAMP on Cortisol Secretion. Bovine AZF cells were
plated as described in the Methods. After 24 h, media was replaced with the same media without (control) or with 8CPT-29-OMe-cAMP or ACTH. A)
Time- and concentration-dependent effects of 8CPT-29-OMe-cAMP on cortisol secretion. Media was sampled and cortisol measured at 4, 24 and 48 h
after treating AZF cells with 8CPT-29-OMe-cAMP at concentrations ranging from 10 to 50 mM. B) Concentration-response curve for 8CPT-29-OMe-
cAMP-stimulated on cortisol secretion after 24 h. Data were fit with an equation of the form: Y=min+(max2min)/(1+10
‘((Log EC502X)*b)) where
EC50 is the concentration that produces 50% of maximal effect and b is the Hill slope. C) Effect of 8CPT-29-OMe-cAMP (30 mM) and ACTH (2 nM) on
cortisol secretion at 1, 2 or 3 h. D) Time course for ACTH (2 nM) and 8CPT-29-OMe-cAMP (30 mM). Media was sampled and cortisol determined at
times from 8 to 96 h.
doi:10.1371/journal.pone.0006088.g001
Cortisol Secretion Pathway
PLoS ONE | www.plosone.org 4 June 2009 | Volume 4 | Issue 6 | e6088Figure 2. Effects of ACTH and 8CPT-29-OMe-cAMP on Expression of Genes Coding for Steroidogenic Proteins. AZF cells were incubated
either without (control), or with 8CPT-29-OMe-cAMP, 8CPT-29-OMe-cAMP plus H-89, or ACTH as indicated. Total RNA was isolated at indicated times. Each
lane contained 10 mg of total RNA. Membranes were hybridized with specific probe for bovine CYP11a1, then stripped and probed for CYP17, stripped
and reprobed for CYP21, as indicated. 18S rRNA bands from representative gels are shown as evidence of even loading. A) Concentration-dependent
effect of 8CPT-29-OMe-cAMP on CYP11a1, CYP17, and CYP21 mRNA. AZF cells were either untreated (control, white bar) or treated with 10–50 mM8 C P T -
29-OMe-cAMP (grey bars) for 48 hr before isolating total RNA. B) Time-dependent effect of 8CPT-29-OMe-cAMP on CYP11a1, CYP17, and CYP21. AZF cells
wereincubatedwithout(control,whitebar),orwith8CPT-29-OMe-cAMP(30 mM)(greybars),orpre-incubatedwithH-89(10 mM)for30 minbeforeadding
8CPT-29-OMe-cAMP (30 mM) (striped/grey bar) for times indicated, after which total RNA was isolated. C) Comparison of time-dependent effects of 8CPT-
29-OMe-cAMP(30 mM)andACTH(2 nM)onCYP17mRNA.AZFcellswereincubatedeitherwithout(control,whitebar)orwith8CPT-29-OMe-cAMP(30 mM,
grey bar) or ACTH (2 nM, black bar) for 0.5 to 4 h (left panel) or 5 to 30 h (right panel), after which total RNA was isolated.
doi:10.1371/journal.pone.0006088.g002
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PLoS ONE | www.plosone.org 5 June 2009 | Volume 4 | Issue 6 | e6088Figure 3. Sp-8CPT-29-OMe-cAMP activates RAP1A but does not increase either Cortisol Secretion or Steroidogenic Protein Gene
Expression. AZF cells were either untreated (control), or incubated with 8CPT-29-OMe-cAMP, or Sp-8CPT-29-OMe-cAMP, as indicated. A) Comparison
of effect of 8CPT-29-OMe-cAMP (50 mM) and Sp-8CPT-29-OMe-cAMP (30, 50, or 100 mM) on cortisol secretion after 48 h. B) Activation of Rap1 by 8CPT-
29-OMe-cAMP and Sp-8CPT-29-OMe-cAMP in AZF cells. For pull-down assays, AZF cells were prepared and cultured in 10 cm dishes as described in
the Methods. Before lysis, cells were incubated for 15 min either without (control) or with 50 or 100 mM 8CPT-29-OMe-cAMP, or 100 mM SP-8CPT-29-
OMe-cAMP. C) Sp-8CPT-29-OMe-cAMP does not increase CYP17 or CYP11a1 mRNA expression. AZF cells were incubated without (control, white bar)
or with either 8CPT-29-OMe-cAMP (30 mM, grey bar), or Sp-8CPT-29-OMe-cAMP (30 mM, striped/grey bar). Total RNA was isolated after 48 h,
electrophoresed, blotted and probed as described in the Methods. Each lane contained 10 mg of total RNA. Membranes were hybridized with specific
probe for bovine CYP11a1 or CYP17, as indicated. D) Cortisol measurements from media samples from experiment illustrated in (C).
doi:10.1371/journal.pone.0006088.g003
Figure 4. Structures of 8CPT-29-OMe-cAMP and Metabolites. Chemical structures of 8CPT-29-OMe-cAMP and its metabolites.
doi:10.1371/journal.pone.0006088.g004
Cortisol Secretion Pathway
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not shown).
8CPT-29-OMe-59AMP itself may be a substrate for 59
nucleotidases that would convert this molecule to 8-(4-chlorophe-
nylthio)-29-O-methyladenosine (8CPT-29-OMe-Ado) (see Figure 4)
[36]. Accordingly, 8CPT-29-OMe-Ado stimulated cortisol secre-
tion and the expression of steroid hydroxylases with characteristics
similar to the parent molecules. In contrast, adenosine was
completely ineffective at stimulating cortisol synthesis or mRNA
expression (Figure 6A,B).
8CPT-29-OMe-Ado may be further metabolized to 8CPT-29-
adenine (8CPT-Ade) by purine nucleoside phosphorylase (see
Figure 4) [36]. 8CPT-Ade also induced a delayed increase in both
cortisol synthesis and expression of steroid hydroxylase mRNA
with a temporal pattern, potency, and effectiveness similar to each
of the previously described putative metabolites (Figure 6C, D).
In summary, the Epac-selective cAMP activator 8CPT-29-
OMe-cAMP stimulated cortico-steroidogenesis by bovine AZF
cells through a mechanism which is likely independent of Epac2
activation. Rather, the steroidogenic effect appears to be mediated
through one or more metabolites that, after several hours delay,
induce the expression of mRNAs coding for steroid hydroxylases
involved in the synthesis of cortisol from cholesterol.
Stimulation of StAR Expression by 8CPT-29-OMe-59AMP
and its Metabolites
The rate-limiting step in ACTH-stimulated cortisol synthesis,
the transfer of cholesterol from the outer to the inner
mitochondrial membrane, is mediated by StAR [7,10,37]. We
found that, in addition to increasing the expression of steroid
hydroxylase genes, 8CPT-29-OMe-cAMP also induced the
expression of StAR mRNA. The potency and temporal pattern
were similar to those observed for increases in steroid hydroxylase
mRNAs (Figure 7A,B). In contrast, Sp-8CPT-29-OMe-cAMP
failed to induce the expression of StAR mRNA, indicating that this
effect was again mediated by one or more metabolites of the
hydrolyzable ESCA (Figure 7C). Accordingly, both 8CPT-29-
OMe-59AMP and 8CPT-adenine stimulated large increases in the
quantity of StAR mRNAs (Figure 7C,D). 8CPT-29-OMe-cAMP
and 8CPT-Ade induced StAR mRNA similarly at concentrations
from 10–50 mM (Figure 7A,D).
Steroidogenic Effects of 8CPT-29-OMe-cAMP are PKA-
independent
Although 8CPT-29-OMe-cAMP is a relatively specific activator
of Epac proteins, it is a weak and less effective activator of PKA
[28,30,35]. It isn’t known whether the putative Epac metabolites
activate PKA at the same concentrations that stimulate cortisol
secretion.
It was discovered that none of these agents increased PKA
activity in AZF cells when they were applied at concentrations
sufficient to induce large increases in cortisol synthesis (Figure 8A).
These metabolites also failed to activate PKA when applied
directly to AZF cell lysates (data not shown).
Cycloheximide Sensitivity
The delay of hours that precedes the 8CPT-29-OMe-cAMP-
induced increase in the expression of genes coding for steroido-
genic proteins suggests that this effect requires de novo protein
synthesis. Accordingly, the protein synthesis inhibitor cyclohexi-
mide (5 mg/ml) inhibited the expression of mRNAs coding for
each of the three steroid hydroxylases and StAR (Figure 8B).
Discussion
The major findings of this study are that the Epac-selective
cAMP analog 8CPT-29-OMe-cAMP induced large, delayed
increases in the expression of mRNAs coding for steroidogenic
proteins, including three steroid hydroxylases and StAR, leading
to corresponding increases in cortisol synthesis. Importantly, these
corticosteroidogenic actions are not mediated by the ESCA itself,
but by one or more enzymatic products of this compound. These
metabolites, including 8CPT-29-OMe-59AMP, 8CPT-29-OMe-
Ado, and 8CTP-Ade, all induce mRNAs and cortisol synthesis
with a potency and temporal pattern similar to the parent
compound, but by an unknown Epac2- and PKA-independent
Figure 5. The 8CPT-29-OMe-cAMP Metabolite 8CPT-29-OMe-59AMP Increases Cortisol Secretion and CYP17 mRNA Expression. A)
Time- and concentration-dependent effects of 8CPT-29-OMe-59AMP on cortisol secretion by AZF cells. AZF cells were treated with 8CPT-29-OMe-
59AMP at concentrations ranging from 0.01 to 100 mM. Cortisol was measured from media samples after 6, 24 and 48 h. B) Concentration-dependent
effects of 8CPT-29-OMe-59AMP on CYP17 mRNA expression. AZF cells were incubated without (control, white bar) or with 0.01–100 mM 8CPT-29-OMe-
59AMP (black bars) for 48 hr before isolating total RNA.
doi:10.1371/journal.pone.0006088.g005
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physiology remains unknown.
8CPT-29-OMe-cAMP and Metabolites
Initial experiments in which the ESCA induced pronounced,
delayed increases in the expression of steroid hydroxylase and
StAR mRNAs and associated cortisol synthesis led us to believe
that these effects were mediated through activation of Epac2
which is robustly expressed in bovine AZF cells [19]. The failure of
Sp-8CPT-29-OMe-cAMP to mimic the actions of its hydrolyzable
analog was unexpected and appears to eliminate the possibility
that ACTH- or cAMP-stimulated increases in cortisol synthesis are
mediated in part by Epac2.
These results also suggested that 8CPT-29-OMe-cAMP
functions in this instance only after conversion to one or more
bioactive metabolites. Accordingly, we found that three potential
metabolites of the ESCA mimicked its effects on cortisol
secretion and gene expression. Enzymes that could catalyze the
conversion of 8CPT-29-OMe-cAMP to each of these presump-
tive metabolites are expressed by mammalian cells. These
include cyclic nucleotide phosphodiesterases, 59nucleotidases,
hypoxanthine phosphoribosyltransferase, and nucleotide phos-
phorylases [36].
Receptors and Signaling Pathways
Currently, the active metabolites, associated receptor, and
signaling pathway(s) that mediate the increases in cortisol synthesis
and gene expression observed in this study have not been
identified. It will be important to learn if 8CPT-Ade is further
metabolized to an active compound.
Figure 6. 8CPT-29-OMe-Adenosine and 8CPT-Adenine Increase Cortisol Secretion and CYP17 mRNA Expression. AZF cells were
incubated either without (control), or with 8CPT-29-OMe-Ado, adenosine, or 8CPT-Ade at concentrations from 1-50 mM. Media was sampled for
cortisol measurements at several time points and total RNA was isolated after 48 h for measurement of CYP17 mRNA. A,B) Time- and concentration-
dependent effects of 8CPT-29-OMe-Ado on cortisol secretion and CYP17 mRNA. A) Media was sampled and cortisol measured at 6, 24 and 48 h after
incubating AZF cells without (control, white bars) or with 8CPT-29-OMe-Ado at concentrations ranging from 1 to 50 mM (grey bars) or adenosine
(50 mM, black bar). B) After 48 h, mRNA was isolated and CYP17 mRNA measured by Northern blot. C, D) Time- and concentration-dependent effects
of 8CPT-Ade on cortisol secretion and CYP17 mRNA. C) Media was sampled and cortisol determined at 6, 24 and 48 h after treating AZF cells without
(control, white bars) or with 8CPT-Ade at concentrations ranging from 1 to 50 mM (dark grey bars). D) After 48 h, mRNA was isolated and CYP17
mRNA was measured by Northern blot.
doi:10.1371/journal.pone.0006088.g006
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PLoS ONE | www.plosone.org 8 June 2009 | Volume 4 | Issue 6 | e6088Figure 7. Effects of 8CPT-29-OMe-cAMP, Metabolites, and Sp-8CPT-29-OMe-cAMP on StAR mRNA Expression. AZF cells were incubated
either without (control), or with 8CPT-29-OMe-cAMP, 8CPT-29-OMe-59AMP, Sp-8CPT-29-OMe-cAMP, or 8CPT-Ade at indicated times. Total RNA was
isolated after indicated times. Membranes were hybridized with specific probe for bovine StAR mRNA as described in the Methods. Each lane
contained 10 mg of total RNA. 18S rRNA bands from representative gels are shown as evidence of even loading. A) Concentration-dependent effect of
8CPT-29-OMe-cAMP on StAR mRNA. AZF cells were incubated without (control, white bar) or with 10–50 mM 8CPT-29-OMe-cAMP (grey bars) for 48 hr
before isolating total RNA. B) Time-dependent effects of 8CPT-29-OMe-cAMP on StAR mRNA. AZF cells were incubated without (control, white bar), or
with 8CPT-29-OMe-cAMP (50 mM, grey bars) for indicated times after which total RNA was isolated. mRNA is expressed as % control value at 72 h. C)
Comparison of effects of 8CPT-29-OMe-cAMP, 8CPT-29-OMe-59AMP, and hydrolysis-resistant Sp-8CPT-29-OMe-cAMP on StAR mRNA. AZF cells were
incubated without (control, white bar) or with either 8CPT-29-OMe-cAMP (30 mM, light grey bar), 8CPT-29-OMe-59AMP (30 mM, dark grey bar), or Sp-
8CPT-29-OMe-cAMP (30 mM, striped/grey bar) for 48 h after which total RNA was isolated. D) Concentration-dependent effect of 8CPT-Ade on StAR
mRNA. AZF cells were incubated without (control, white bar) or with 10–50 mM 8CPT-Ade (grey bars) for 48 hr before isolating total RNA.
doi:10.1371/journal.pone.0006088.g007
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that it acts through a signaling pathway that is different from those
activated by cAMP. First, in contrast to cAMP which triggers both
rapid and delayed increases in cortisol synthesis through PKA-
dependent mechanisms, 8CPT-29-OMe-cAMP and its metabolites
stimulate only delayed increases in cortisol without activating PKA
[1,13,38].
The activation of Rap1 by 8CPT-29-OMe-cAMP and it non-
hydrolyzable analog were not correlated with the expression of
steroidogenic mRNAs or cortisol production. In fact, 8CPT-29-
OMe-cAMP stimulated cortisol synthesis at concentrations that
produced little or no Rap1 activation, while at higher concentra-
tions, Sp-8CPT-29-OMe-cAMP activated Rap1 without increas-
ing cortisol synthesis. These results argue against any role for
Epac2 in cAMP-stimulated cortico-steroidogenesis.
Overall, the findings of this study do not rule out the
possibility that an ESCA metabolite functions through an
unknown cAMP-independent pathway which may also be activated
by ACTH. ACTH and an O-nitrophenyl sulphenyl derivative
produce large increases in cortisol synthesis at concentrations that
stimulate no measurable increase in cAMP production [39,40].
Alternatively, metabolite-sensing riboswitches, including those
binding adenine and adenine derivatives, control gene expression
in prokaryotes as well as eukaryotes [41,42]. It is not known whether
hormone synthesis in eukaryotic cells could also be regulated by
small molecules acting through riboswitches. ESCA metabolites
could also activate unidentified orphan receptors.
The delay of several hours and the cycloheximide-sensitivity
indicate that 8CPT-29-OMe-cAMP-stimulated mRNA expression
and cortisol secretion require de novo protein synthesis. It is possible
that the active molecule induces the expression of a transcription
factor that specifically enhances the transcription of genes
coding for steroidogenic proteins. In this regard, we found that
8CPT-29-OMe-cAMP and its metabolites do not stimulate the
Figure 8. Effects of 8CPT-29-OMe-cAMP and Metabolites are PKA-independent but Cycloheximide-sensitive. A) Effect on PKA activity.
AZF cells were either untreated (control), or incubated with ACTH (2 nM), 8CPT-29-OMe-cAMP (30 mM), Sp-8CPT-29-OMe-cAMP (30 mM), 8CPT-29-OMe-
ado (30 mM), or 8CPT-ade (30 mM) for 30 min after which lysates were collected and assayed for PKA activity as described in the Methods. PKA activity
is expressed as mean6SEM of duplicate determinations from duplicate independent samples. B) Effect of cycloheximide on 8CPT-29-OMe-cAMP-
dependent increases in steroidogenic and StAR mRNAs. AZF cells were either untreated (control, white bar), or incubated with cycloheximide (CH,
5 mg/ml, striped bar), 8CPT-29-OMe-cAMP (30 mM, grey bar), or 8CPT-29-OMe-cAMP plus CH (striped/grey bar), as indicated. Total RNA was isolated
after 48 h. Membranes were hybridized with specific probes for StAR, CYP11a1, CYP17, or CYP21 mRNA. Each lane contained 10 mg of total RNA. StAR
mRNA value was determined from % control for the 2.75 Kb band value.
doi:10.1371/journal.pone.0006088.g008
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including the transcriptional repressor DAX-1 and the Kv1.4 K
+
channel (unpublished observations). However, the range of genes
whose expression might be increased or decreased through this
novel signaling pathway is yet to be determined. It will be
interesting to compare ACTH and cAMP to 8CPT-Ade with
respect to their effects on the expression of the entire transcrip-
tome of bovine AZF cells.
Neither 8CPT-29-OMe-cAMP nor its presumptive metabolites,
at concentrations that triggered large increases in cortisol
synthesis, increased overall RNA synthesis or AZF cell prolifer-
ation. Rather, these agents had a slight inhibitory effect on
proliferation. Therefore, none of the delayed increases in cortisol
synthesis could be attributed to increases in the number of AZF
cells (unpublished observations).
Since its introduction in 2002, 8CPT-29-OMe-cAMP has been
used in hundreds of studies to determine whether Epacs regulate
the function of cellular proteins, including ion channels and
enzymes and processes ranging from secretion and cell adhesion to
hormone gene expression [16,28,30]. The discovery that one or
more metabolites of the ESCA 8CPT-29-OMe-cAMP markedly
induce cortisol secretion and the expression of four associated
genes indicates that the results of studies in which this compound
has been used as a selective activator of Epac proteins may require
re-evaluation. Further, to confirm that a cellular response is
mediated through Epac1 or Epac2, it should be produced by
hydrolyzable as well as non-hydrolyzable Epac activators.
The extent to which metabolites of ESCAs might regulate gene
expression and cell function in other tissues and organisms is
unknown. Perhaps these agents will regulate the synthesis of other
steroid hormones, including the adrenal mineralocorticoid aldo-
sterone, and the gonadal steroids testosterone and estrogen [20]. It
has been reported that 8CPT-29-OMe-cAMP metabolites also
inhibit proliferation of the protozoa Trypanosoma brucei [43]. It is
possible that these responses might involve activation of a common
ancient signaling pathway present in both prokaryotes and
eukaryotes.
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